We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
)
InterviewBusiness and Biotech: Mayra Battilani on Strategy, Access and the Future of Advanced Therapies
Mayra Battilani Becegato, former EMEA Commercial Strategy Director for Gene Therapy – Rare Diseases at Johnson & Johnson ... -
)
Barcelona is a thriving strategic hub for advanced therapies. At Advanced Therapies Europe 2025, the city becomes more t ... -
)
Get an exclusive first look at what’s in store for Advanced Therapies Europe 2025. This live webinar will explore the ke ... -
)
AI and machine learning have long promised to revolutionize the cell and gene therapy industry—but how much of that prom ... -
)
InterviewFrom Vision to Impact: How Marion Hitchcock Is Powering Europe’s Gene & Cell Therapy Startups
Marion Hitchcock, Managing Director of the Gene & Cell Therapies Incubator Berlin and R&D Strategy & Portfolio Manager a ... -
)
This case study showcases the successful expansion of mesenchymal stem cells (MSCs) using Rooster Bio's xeno-free MSC pl ... -
)
To meet the growing demand for advanced therapies, supply chain models must become more agile, collaborative, and patien ... -
)
Fresenius Kabi is advancing cell therapy manufacturing with flexible, automation-ready solutions. In this AT-TV intervie ... -
)
Bionova Scientific is expanding into advanced therapies with a new plasmid DNA manufacturing facility in The Woodlands, ... -
)
In this AT-TV episode from Advanced Therapies Week 2025, Ben McLoud interviews Rohan Iyer, Senior Director of Global Cel ... -
)
PHC Corporation of North America showcases LiCellMo™, their live cell metabolic analyzer, during Advanced Therapies Week ... -
)
Charles River Laboratories has launched a global biotech incubator and accelerator program designed to help cell and gen ... -
)
Emerson’s life sciences leaders share how their automation and software solutions are driving operational efficiency, fl ... -
)
InterviewEmbracing Innovation to Fight the Good Fight: Lowering the Costs of Viral Vector Manufacture
At Advanced Therapies Week 2025, ProteoNic shared how its proprietary promoter and enhancer technology is helping reduce ... -
)
A fireside chat from Advanced Therapies Week 2025 features women leaders shaping the future of cell and gene therapy. Ca ... -
)
At Advanced Therapies Week 2025, Cryoport Systems joined AT-TV to unveil their latest advancements in cold chain logisti ... -
)
At Advanced Therapies Week 2025, Repligen’s Rachel Legmann shares expert insights on overcoming manufacturing challenges ... -
)
OmniaBio shares how its new commercial CDMO facility in Canada is redefining advanced therapies manufacturing. In this A ... -
)
Cardinal Health is transforming the delivery landscape for advanced therapies with a unified, national white glove logis ... -
)
With the rise of allogeneic cell therapies, the cell and gene therapy industry stands at a potential turning point. In t ... -
)
As gene therapies expand their clinical development and therapeutic reach Biotech’s are always looking for better ways o ... -
)
In this in-depth interview with Genezen’s Founder and Executive Chairman, Bill Vincent, we unpack the evolving landscape ... -
)
Adeno-associated viral vectors have quickly become the vector of choice for many gene therapy developers. With a strong ... -
)
Over the past two decades, advanced therapies have transformed healthcare—from the first FDA-approved cell therapy to CR ...